scorecardresearchShilpa Medicare Share Price Live NSE, BSE, Today - Shilpa Medicare Stock
Mintgenie
Asian Paints2,808.45-6.30 (-0.22%)
Axis Bank1,029.505.35 (0.52%)
Bajaj Finance7,107.00217.75 (3.16%)
Bajaj Finserv1,619.6025.35 (1.59%)
Bharti Airtel1,289.3022.10 (1.74%)
HCL Technologies1,450.00-17.65 (-1.20%)
HDFC Bank1,531.3036.70 (2.46%)
Hindustan Unilever2,232.2517.30 (0.78%)
ICICI Bank1,066.4010.95 (1.04%)
ITC424.805.85 (1.40%)
Indusind Bank1,485.8011.85 (0.80%)
Infosys1,411.60-8.95 (-0.63%)
Kotak Mahindra Bank1,790.003.55 (0.20%)
Larsen & Toubro3,519.25-31.70 (-0.89%)
Mahindra & Mahindra2,082.9058.75 (2.90%)
Maruti Suzuki India12,669.35273.05 (2.20%)
NTPC350.90-0.50 (-0.14%)
Nestle India2,437.10-25.65 (-1.04%)
Power Grid Corporation Of India281.701.50 (0.54%)
Reliance Industries2,941.6013.45 (0.46%)
State Bank Of India750.806.00 (0.81%)
Sun Pharmaceutical Industries1,525.007.85 (0.52%)
Tata Consultancy Services3,827.45-36.05 (-0.93%)
Tata Motors963.20-8.20 (-0.84%)
Tata Steel162.102.10 (1.31%)
Tech Mahindra1,193.7513.90 (1.18%)
Titan Company3,563.8037.40 (1.06%)
Ultratech Cement9,399.1011.90 (0.13%)
Wipro452.858.55 (1.92%)

Shilpa Medicare

BSE: 530549 | NSE: SHILPAMED | ISIN: INE790G01031 | SECTOR: Biotechnology & Drugs

₹534.25 8.25 (1.57%)

19 Apr 2024, 09:59 (IST)

  • Open

    523.10

  • High

    541.00

  • Low

    515.00

  • Prev Close

    526.00

  • P/E

    -

  • Median P/E

    -

  • P/B

    -

  • Median P/B

    -

  • Market Cap

    52.24B

  • Volume

    63.87K

  • Vol. (20 day Avg.)

    0

  • PEG

    -

  • Div.Yield

    -

  • Bid

    -

  • Ask

    -
View all metrics

Promoter Pledge Holding - 40.13%

Promoter NameNo of SharesPercentage
VISHNUKANT CHATURBHUJ BHUTADA63,65,6106.51%
DHARMAVATI BHUTADA62,07,7966.35%
DEEPAK KUMAR INNANI27,33,9602.80%
KANTADEVI INANI25,40,0962.60%
OM PRAKASH INANI28,67,6912.93%
KESHAV BHUTADA20,00,0002.05%
RAVI KUMAR INNANI40,06,3704.10%
MADHAV VISHNUKANT BHUTADA20,00,0002.05%
VISHNUKANTH C BHUTADA13,36,1301.37%
VISHNUKANTA INANI12,12,4981.24%
BRIJGOPAL INNANI11,74,8661.20%
TARADEVI INNANI12,49,9981.28%
RAMAKANT INNANI14,97,7781.53%
MANJULATHA INNANI1,57,5460.16%
SHAKUNTALABAI INNANI11,29,1861.15%
NAMRATA BHUTADA22,5000.02%
KEERTI INNANI1,55,0210.16%
KAMALKISHORE INNANI1,65,2360.17%
SAGAR INNANI10,00,0001.02%
NATAMAL INNANI11,31,2321.16%
TRIVENI INANI2,94,8100.30%

Company Description

  • Biotechnology & Drugs

  • BSE

    530549

  • NSE

    SHILPAMED

  • ISIN

    INE790G01031

Shilpa Medicare Limited is an India-based pharmaceutical company. The Company is engaged in research and development, manufacturing and sale of oncology drugs and formulations. Its products consist of oncology and non-oncology active pharmaceutical ingredients (APIs), oncology formulations, biosimilars, ophthalmic, oral dissolving films, biochemical diagnostics, organic intermediates, pilot and production scales and transdermal patches. It supplies oncology APIs and intermediates. Its oncology/non-oncology APIs include Capecitabine, Gemcitabine Hydrochloride, Axitinib, Erlotinib HCL, and Irinotecan HCL Trihydrate for various regulated markets, including United States of America, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-oncology APIs products include Ambroxol (Mucolytic agent) in Europe and Tranexmic Acid and Ursodeoxycholic acid in India. It is also engaged in manufacturing and sale of Lenvatinib Capsules under the brand name Lenshil.

Company Officers

  • Alpesh Dalal

    Chief Financial Officer

  • Ritu Tiwary

    Compliance Officer, Company Secretary

  • Vishnukant Bhutada

    Managing Director, Executive Director

  • Sharath Kalakota

    Whole-Time Director